Search results
Author(s):
John M Miller
,
Anil V Yadav
Added:
3 years ago
In the nearly 30 years since Wellens et al. categorized most of the currently used electrocardiographic (ECG) criteria for distinguishing supraventricular tachycardia (SVT) with aberrant interventricular conduction from ventricular tachycardia (VT),1 there have been relatively infrequent and largely incremental enhancements to the art and science of making this distinction. In most published…
View more
Author(s):
Joo-Yong Hahn
Added:
1 year ago
ACC.23/WCC - Principal investigator, Dr Joo-Yong Hahn (Samsung Medical Center, KR) joins us to discuss the findings of the RENOVATE-COMPLEX-PCI late-breaking trial (Samsung Medical Center). The investigators compared clinical outcomes between intravascular imaging guided (IVUS) versus angiography guided (OCT) percutaneous coronary intervention (PCI) in 1639 patients with complex lesions …
View more
Author(s):
Bill D Gogas
,
Duk-Woo Park
Added:
2 years ago
In this video, USC Editor-in Chief Dr Bill Gogas discusses the upcoming 2021 Complex PCI event with Dr Duk-Woo Park (Asan Medical Center, Seoul, KR). Dr Park provides an overview of what we can expect to see at Complex PCI this year.
View more
PCI in Women
Author(s):
Mirvat Alasnag
,
Valeria Paradies
,
Nicola Ryan
,
et al
Added:
4 months ago
Article
Author(s):
Srinivas Murali
Added:
3 years ago
Introduction
Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and…
View more
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
6 months ago
Author(s):
Srinivas Murali
Added:
3 years ago
Pulmonary arterial hypertension (PAH) is a disease affecting the pulmonary vascular endothelium of the small pulmonary vessels that causes progressive elevations in pulmonary vascular resistance, leading to right ventricular failure and death. PAH can result from a number of causes or associated risk factors. A clinical classification (Evian classification) was developed in 1993 and subsequently…
View more
Author(s):
Alexander G Truesdell
,
Rhian E Davies
,
Moemen Eltelbany
,
et al
Added:
1 year ago
Role of IVUS in Complex PCI
Author(s):
Brandon Quintana
,
Akram Ibrahim
Added:
3 years ago
Article